PathoQuest
PathoQuest is a biotechnology company identifying pathogens through High Throughput Sequencing (HTS)..
Launch date
Employees
Market cap
-
Enterprise valuation
CAD90—135m (Dealroom.co estimates Nov 2021.)
Company register number 524876059
Paris Île-de-France (HQ)
Financials
Estimates*
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | <1m | <1m | 1.6m | 2.8m | 3.1m | 4.1m | 4.1m |
| % growth | 763 % | 82 % | 102 % | 75 % | 13 % | 33 % | - |
| EBITDA | (2.8m) | (3.6m) | (3.8m) | (3.5m) | (4.1m) | - | - |
| % EBITDA margin | (640 %) | (457 %) | (243 %) | (127 %) | (130 %) | - | - |
| Profit | (2.6m) | (3.4m) | (3.8m) | (3.5m) | (4.9m) | - | - |
| % profit margin | (615 %) | (441 %) | (240 %) | (128 %) | (155 %) | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - |
| N/A | - |
* | N/A | Spinout | |
| N/A | €2.0m | Early VC | |
€4.5m | Early VC | ||
€2.0m | Early VC | ||
€4.0m | Early VC | ||
€8.0m | Series A | ||
* | €15.0m | Series B | |
| Total Funding | CAD53.2m | ||
Related Content
Recent News about PathoQuest
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.